Bioresorbable Stents for the Treatment of Cardiovascular Indications (coronary artery disease)

Home  /  National Uptake and Case Studies  /  Bioresorbable Stents for the Treatment of Cardiovascular Indications (coronary artery disease)
CountryAgencyYear work was carried outLinkDetails of use
AustriaLBI-HTA2019-National Adaptation. Added executive summary in German.
CroatiaAAZ2019-Dissemination - Prepared the summary and assessment elements B0001 and A0020 in Croatian (will be published on the AAZ website along with links to the full EUnetHTA assessment).
NorwayNIPHNOOngoing-Dissemination - Informed the National Commission Forum for Introduction of New Technologies into the Norwegian Specialist Health Care about the assessment.
RomaniaNSPHMPDB2019-Dissemination - Letter to the MoH. Link on the NSPHMPDB Facebook page.
SpainSCS2019-Dissemination – seminars and courses.
SwedenSBU2019-Dissemination.
United Kingdom (England)NICE2019LINKDissemination – incorporated into NHS Evidence as a source of information for clinicians.
United Kingdom (Scotland)SHTG2019-.Dissemination to clinical directorate to assess level of interest in this technology in Scotland.
United Kingdom (Wales)HTWOngoing-Shared with national Welsh procurement committee considering stent use. Use of HTA to be determined.